PMID- 2207333 OWN - NLM STAT- MEDLINE DCOM- 19901119 LR - 20210216 IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 76 IP - 8 DP - 1990 Oct 15 TI - Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself. PG - 1631-8 AB - We investigated the effects of recombinant C5a (rC5a) on gene expression and synthesis of interleukin-1 beta (IL-1 beta) and tumor necrosis factor (TNF) in fresh human peripheral blood mononuclear cells (PBMC). Total (cell-associated and secreted) cytokine synthesis was measured. In the strict absence of endotoxin (lipopolysaccharide [LPS]), rC5a resulted in a small but statistically insignificant increase in immunoreactive IL-1 beta and TNF, as well as in IL-1 and IL-6 bioactivity. On the other hand, rC5a induced marked transcriptional activation of IL-1 beta and TNF in a dose-dependent fashion with an optimal concentration of 50 ng/mL. The rC5a-induced cytokine messenger RNA (mRNA) was not spontaneously translated into protein. At 50 ng/mL, rC5a induced the same levels of mRNA for IL-1 beta and TNF as 1 ng/mL of LPS, whereas LPS induced 12 times more IL-1 beta protein and 70 times more TNF protein than rC5a alone. The C5a-induced mRNA half-life was the same as that induced by LPS. Formyl-Meth-Leu-Phe (fMLP) did not induce cytokine transcription. Pretreatment with rC5a enhanced cytokine synthesis induced by other stimuli. After 2 hours of preincubation with rC5a, PBMC synthesized 3 to 10 times more IL-1 beta and TNF on subsequent stimulation by LPS or IL-1 itself. We conclude that rC5a provides primarily a transcriptional but not translational signal for IL-1 beta and TNF; the half-life of the untranslated mRNA is the same as that of translated message; rC5a-induced transcription upregulates PBMC for enhanced synthesis of these cytokines; and a translational signal can be provided by LPS or IL-1 itself. FAU - Schindler, R AU - Schindler R AD - Department of Medicine, Tufts University School of Medicine, Boston, MA. FAU - Gelfand, J A AU - Gelfand JA FAU - Dinarello, C A AU - Dinarello CA LA - eng GR - AI 15614/AI/NIAID NIH HHS/United States GR - GM-21700/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Interleukin-1) RN - 0 (Lipopolysaccharides) RN - 0 (RNA, Messenger) RN - 0 (Recombinant Proteins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - 80295-54-1 (Complement C5a) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Complement C5a/*pharmacology MH - Gene Expression MH - Humans MH - Interleukin-1/biosynthesis/*genetics/pharmacology MH - Lipopolysaccharides/*pharmacology MH - N-Formylmethionine Leucyl-Phenylalanine/pharmacology MH - *Protein Biosynthesis MH - RNA, Messenger/biosynthesis MH - Recombinant Proteins/pharmacology MH - Tetradecanoylphorbol Acetate/pharmacology MH - *Transcription, Genetic MH - Tumor Necrosis Factor-alpha/biosynthesis/*genetics EDAT- 1990/10/15 00:00 MHDA- 1990/10/15 00:01 CRDT- 1990/10/15 00:00 PHST- 1990/10/15 00:00 [pubmed] PHST- 1990/10/15 00:01 [medline] PHST- 1990/10/15 00:00 [entrez] AID - S0006-4971(20)75237-7 [pii] PST - ppublish SO - Blood. 1990 Oct 15;76(8):1631-8.